Connect with us

COVID-19 Around the World

Vaxzevria: saving the rest of the world

Published

on

Today, the coronavirus landscape – and the status of their jab, ChAdOx1 nCoV-19 – looks very different. In the UK, half the population have had their vaccine, restrictions have ended, and while cases and hospitalisations are rising in the UK, a dramatic uptick in deaths is not expected. The jab has saved more than a million lives, according to estimates, but its reputation has been battered by a toxic mix of misinformation, miscommunication and mishaps. Two years after Pollard, Gilbert and their teams first began making the miracle jab now known as Vaxzevria or Covishield, it has been sidelined in the UK and Europe, and snubbed in the US.

Instead, ChAdOx1 nCoV-19 is gearing up for what will probably be its final act: saving the rest of the world. About 2.6bn doses of it have been distributed to 183 countries, but 3 billion people have yet to receive a first dose of any Covid jab. The highly infectious Omicron variant is flagging in the west, but new cases are soaring in less-vaccinated areas. Globally, daily cases remain high, averaging about 1.8m – three times the 600,000 a day in December. Cases are rising in the Middle East, Asia and Latin America, and the low cost and ease with which the Oxford/AstraZeneca vaccine could be deployed to these regions, as well as the more “inaccessible parts of the world”, meant the jab could still play a crucial role in helping end the pandemic, Pollard said.

 

 

Instead, ChAdOx1 nCoV-19 is gearing up for what will probably be its final act: saving the rest of the world. About 2.6bn doses of it have been distributed to 183 countries, but 3 billion people have yet to receive a first dose of any Covid jab. The highly infectious Omicron variant is flagging in the west, but new cases are soaring in less-vaccinated areas. Globally, daily cases remain high, averaging about 1.8m – three times the 600,000 a day in December. Cases are rising in the Middle East, Asia and Latin America, and the low cost and ease with which the Oxford/AstraZeneca vaccine could be deployed to these regions, as well as the more “inaccessible parts of the world”, meant the jab could still play a crucial role in helping end the pandemic, Pollard said.

 

Two years after the jab’s inception, Pascal Soriot, the chief executive of AstraZeneca, insists he has no regrets. “It is really hard to regret anything when you have delivered 2.6bn doses of vaccine, saved 1 million lives around the world and enabled economies in many countries to restart,” he said. “A lot of people focus on some of the challenges that we faced in parts of the world, but I would like to remind everybody again that the US and Europe represent about 10% of the world’s population.”

 

 

Indeed, a data analysis for the Guardian by Airfinity, the health analytics company, reveals that despite the jab’s trials and tribulations, it is already reaching every corner of the globe. Among the 2.6bn doses delivered, 166m have gone to Brazil, 84m to Mexico, 60m to Vietnam, 54m to the Philippines, 19m to Nigeria, and 16m to Iran, for example. Even Germany and France, once the sources of slipshod reporting and false claims about the jab, have quietly accepted 31m and 10m doses respectively, the analysis reveals.

 

Despite the early “excessive hype”, Tang says it remains an “effective” and “useful” vaccine that can still play a big role. “The AZ vaccine is cheap, easy to store and its overall efficacy is still generally sufficient to roll out across many countries to offer protection against severe Covid-19.” Designed to be sold not-for-profit – for about £3 a dose, a fifth of the price of Pfizer’s jab – it recently started turning a modest profit. Rivals have made tens of billions of dollars but Pollard calls AstraZeneca “morally brave” for ignoring the “perverse commercial incentive in a pandemic to sell first to the rich”. A spokesperson says low-income nations will continue to receive the vaccine on a not-for-profit basis.

AstraZeneca is under contract to deliver a further 1.4bn doses worldwide this year, according to a second Airfinity data analysis for the Guardian. “We estimate these [orders] will be fulfilled by the autumn,” said Matt Linley, Airfinity’s analytics director. Some of AstraZeneca’s 25 facilities in 15 countries will reduce their output after that, he expects. “However, we do not foresee demand for the AstraZeneca jab ending completely,” Linley added. “There will remain a need for it, although at a much lower level, especially in difficult to reach parts of the world.”

Continue Reading

COVID-19 Around the World

Weekly news at a glance

Published

on

By

(Worldwide) Covid positive kids separated from parents in Shanghai

A hospital in Shanghai is sending COVID-positive children and parents to different quarantine facilities, an online debate has revealed. Unverified images of children, three-to-a-cot, being tended to by workers in hazmat suits circulated on the WeChat social media platform.

The centre accused of housing the children, the Shanghai Public Health Clinical Centre in the city’s Jinshan district, took to the social media site to debunk the rumours, but in doing so confirmed the existence of the quarantine site.

It added it had organised for more paediatric workers and would strengthen communication with the children’s parents in the wake of criticism from parents whose children have been housed in the facility.

 

(Worldwide) U.S. drops COVID testing for air travelers

In one of the most anticipated travel developments this year, the US Centers for Disease Control and Prevention is poised to lift its requirement for travelers to test negative for Covid-19 before entering the United States, CNN learned on Friday.

The measure has been in place since January 2021. The move is likely to encourage travelers around the world to plan a summer vacation in the States and encourage more US travelers to venture abroad knowing they’re less likely to get stranded overseas with a positive test. Air travel has been far from smooth this season so far.

 

(Worldwide) Face of Hospitality in the Post-Covid World

Studies show that consumer spending on discretionary items like travel, eating out, entertainment etc would stay low and focus would stay on the basics like groceries, internet and mobile services etc. This indicates that there is still time for the hospitality industry to reach its glory of the pre-pandemic times. Similarly, those businesses that depend on the travel and tourism sector are likely to suffer the lul.

Hotels depend heavily on the revenue they generate from business travelers. But, given the current scenario, that too will take time to recover. With the death of many organizations that funded such business travel, it is likely that about 5-10% of it would never return. This makes it imperative that the businesses keep a close watch on the trends that determine the future of the hospitality and tourism industry and plan accordingly.

 

(AUS) Tutors in high demand, but doubts on program for next year

The state government’s 480 million dollar coronavirus catch-up tutoring program has been compromised by teacher shortages, due to COVID and influenza. The program aimed to benefit all government and low-fee private schools in helping students whose learning stalled during the pandemic.

According to Andrew Dalgleish, president of the Victorian Principals Association, most schools were forced to replace sick staff with the tutors to take whole classes. Victorian government awaits a final report before considering if it will recommit to the program.

 

(AUS) COVID-19 vaccine booster available for at-risk children aged 12 to 15

Children aged 12 to 15 years, who are severely immunocompromised and children with a disability, are eligible for a COVID-19 booster vaccine from this week. The Australian Technical Advisory Group on Immunisation has recommended extending eligibility for the Pfizer booster to about 120-thousand children.

Those eligible must have received their second dose at least three months ago, be severely immunocompromised, have a disability, or complex health conditions which increase the risk of severe COVID-19. Children who are NOT considered at-risk, who have received two vaccine doses, are still considered to be well protected against severe disease.

 

(AUS) Free flu vaccinations for Victoria

Free flu vaccinations are available to anyone aged 6 months and over until 30 June. Everyone aged 6 months and older is recommended to get the flu vaccine, especially people aged 65 years and over, people at higher risk of serious illness of complications from flu, pregnant women and children under 5 years.

The COVID-19 vaccine does not protect you against flu, you still need to get the flu vaccine. The best protection for families and communities this winter is to get vaccinated against both flu and COVID-19.

Continue Reading

COVID-19 Around the World

Covid in North Korea

Published

on

Top North Korean officials discussed revising anti-epidemic restrictions on Sunday as they assessed the situation over the country’s first acknowledged COVID-19 outbreak was “improving”, state media reported.

A politburo meeting guided by leader Kim Jong Un “made a positive evaluation of the pandemic situation being controlled and improved across the country and discussed the issues of continuously stabilising and improving the overall anti-epidemic situation,” said KCNA news agency.

North Korea reported no new deaths among fever patients for a second consecutive day, and said 89,500 more people showed fever symptoms on Sunday.

That is down from nearly 400,000 about 11 days ago.

The isolated country has been fighting an unprecedented COVID wave since declaring a state of emergency and imposing a nationwide lockdown this month, fuelling concerns about lack of vaccines, medical supplies and food.

Efforts to strengthen anti-epidemic measures were being taken across North Korea, including collecting rain water, examining virus-resistant medicines and setting up quarantine places, KCNA said.

Many outside experts say North Korea is clearly understating its fatality rate to prevent any political damage to Kim at home.

They say North Korea should have suffered many more deaths because its 26 million people are largely unvaccinated against COVID-19 and it lacks the capacity to treat patients with critical conditions.

Others suspect North Korea might have exaggerated its earlier fever cases to try to strengthen its internal control of its population.

Since its May 12 admission of the Omicron outbreak, North Korea has only been announcing the number of patients with feverish symptoms daily, but not those with COVID-19, apparently because of a shortage of test kits to confirm coronavirus cases in large numbers.

But many outside health experts view most of the reported fever cases as COVID-19, saying North Korean authorities would know how to distinguish the symptoms from fevers caused by other prevalent infectious diseases.

The outbreak has forced North Korea to impose a nationwide lockdown, isolate all work and residential units from one another and ban region-to-region movements.

The country still allows key agricultural, construction and other industrial activities, but the toughened restrictions have triggered worries about its food insecurity and a fragile economy already hit hard by pandemic-caused border shutdowns.

Some observers say North Korea will likely soon declare victory over COVID-19 and credit it to Kim’s leadership.

Yang Un-chul, an analyst at the private Sejong Institute in South Korea, said the North’s recently elevated restrictions must be dealing a serious blow to its coal, agricultural and other labour-intensive industrial sectors.

But he said those difficulties won’t likely develop to a level that threatens Mr Kim’s grip on power, as the COVID-19 outbreak and strengthened curbs have given him a chance to boost his control of his people.

Continue Reading

COVID-19 Around the World

Shanghai ease Covid isolation

Published

on

A partial reopening of stores and offices in Beijing on Sunday was welcomed by a weary populace and struggling shopkeepers eager for life to return to normal. Coupled with a gradual easing of restrictions in Shanghai, it signalled the worst was over in the twin outbreaks in China’s most prominent cities.

More people have been allowed out of their homes, and more businesses are permitted to reopen, although most residents remain largely confined to their housing compounds, with shops mainly limited to deliveries.

Restaurants remain closed in Beijing, except for takeout and delivery, and many people in Shanghai still can only go out with special passes and for a limited time period, even as the number of new cases has plummeted. Shanghai aims to essentially end its lockdown from Wednesday after relaxing restrictions over the past week. 

Shanghai officials urged continued vigilance, even though the vast majority of its 25 million residents live in areas that are in the lowest-risk “prevention” category.

“Wear masks in public, no gathering and keep social distance,” Shanghai Municipal Health Commission’s deputy director, Zhao Dandan, told a daily news conference.

China reports 362 new cases

On Friday, Shanghai’s suburban Fengxian district cancelled a requirement for residents to have a pass to go out.

The state-run Shanghai Securities News reported modest steps towards a return to normality for the financial sector, with the more-than-10,000 bankers and traders who have been living and working in their offices since the start of lockdown gradually returning home.

On Saturday, the country reported 362 daily COVID-19 cases, down from 444 a day earlier. In Beijing, new Friday infections fell to 24 from 29.

While Shanghai officials reported one community-level case in the Songjiang district, they expressed confidence in the steps they were taking to trace and control the infection chain.

“If these measures are implemented effectively, we can prevent a rebound of the epidemic, even if there are sporadic cases, so don’t worry,” Shanghai Centre for Disease Control and Prevention’s deputy director, Sun Xiaodong, said.

Beijing officials say outbreak ‘effectively under control’

In Beijing, new cases have trended lower for six days, with no fresh infections outside of quarantine areas reported on Friday.

The outbreak that began on April 22 is “effectively under control”, a city government spokesman told a news conference.

Starting on Sunday, shopping malls, libraries, museums, theatres and gyms will be allowed to reopen — with limits on the numbers of people allowed — in the eight of Beijing’s 16 districts that have seen no community cases for seven consecutive days.

Two of the districts will end work-from-home rules, while public transportation will largely resume in three districts, including Chaoyang, the city’s largest.

While nationwide case numbers are improving, China’s strict adherence to its “zero-COVID” strategy has devastated the world’s second-largest economy and rattled global supply chains.

The lockdowns and other restrictions under China’s “zero-COVID” strategy have increasingly frustrated residents as they see other countries ease up and re-open their borders. 

Some have resisted and staged protests at apartment complexes and university dormitories, in an authoritarian country where people think twice about speaking out publicly because of possible repercussions.

Officials tend to err on the side of caution under a system that readily punishes them for lax enforcement if outbreaks flare up or come back.

Continue Reading

Trending